AAAAAA
Results:
1-22
|
Results: 22
Authors:
Mock, P
Olivennes, F
Doumerc, S
Frydman, R
Fernandez, H
Citation: P. Mock et al., Simultaneous bilateral tubal pregnancy after intracytoplasmic sperm injection treated by conservative medical treatment - Interest of sonographic follow-up, EUR J OB GY, 94(1), 2001, pp. 155-157
Authors:
Olivennes, F
Mannaerts, B
Struijs, M
Bonduelle, M
Devroey, P
Citation: F. Olivennes et al., Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatmentduring ovarian stimulation for conventional IVF or ICSI: a preliminary report, HUM REPR, 16(8), 2001, pp. 1588-1591
Authors:
Fanchin, R
Ayoubi, JM
Righini, C
Olivennes, F
Schonauer, LM
Frydman, R
Citation: R. Fanchin et al., Uterine contractility decreases at the time of blastocyst transfers, HUM REPR, 16(6), 2001, pp. 1115-1119
Authors:
Ayoubi, JM
Fanchin, R
Olivennes, F
Fernandez, H
Pons, JC
Citation: Jm. Ayoubi et al., Tubal curettage: a new conservative treatment for haemorrhagic interstitial pregnancies, HUM REPR, 16(4), 2001, pp. 780-781
Authors:
Fanchin, R
Righini, C
Schonauer, LM
Olivennes, F
Cunha, JS
Frydman, R
Citation: R. Fanchin et al., Vaginal versus oral E-2 administration: effects on endometrial thickness, uterine perfusion and contractility, FERT STERIL, 76(5), 2001, pp. 994-998
Authors:
Fanchin, R
Righini, C
de Ziegler, D
Olivennes, F
Ledee, N
Frydman, R
Citation: R. Fanchin et al., Effects of vaginal progesterone administration on uterine contractility atthe time of embryo transfer, FERT STERIL, 75(6), 2001, pp. 1136-1140
Authors:
Ludwig, M
Riethmuller-Winzen, H
Felberbaum, RE
Olivennes, F
Albano, C
Devroey, P
Diedrich, K
Citation: M. Ludwig et al., Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix, FERT STERIL, 75(1), 2001, pp. 18-22
Authors:
Olivennes, F
Ayoubi, JM
Fanchin, R
Rongieres-Bertrand, C
Hamamah, S
Bouchard, P
Frydman, R
Citation: F. Olivennes et al., GnRH antagonist in single-dose applications, HUM REP UPD, 6(4), 2000, pp. 313-317
Authors:
Olivennes, F
Fanchin, R
Righini, C
Ledee, N
Frydman, R
Citation: F. Olivennes et al., In vitro fertilization and embryo transfer: present and future aspects, M S-MED SCI, 16(3), 2000, pp. 316-323
Authors:
Christin-Maitre, S
Olivennes, F
Dubourdieu, S
Chabbert-Buffet, N
Charbonnel, B
Frydman, R
Bouchard, P
Citation: S. Christin-maitre et al., Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation, CLIN ENDOCR, 52(6), 2000, pp. 721-726
Authors:
Fanchin, R
Ayoubi, JM
Olivennes, F
Righini, C
de Ziegler, D
Frydman, R
Citation: R. Fanchin et al., Hormonal influence on the uterine contractility during ovarian stimulation, HUM REPR, 15, 2000, pp. 90-100
Authors:
Olivennes, F
Citation: F. Olivennes, Double trouble: yes a twin pregnancy is an adverse outcome, HUM REPR, 15(8), 2000, pp. 1663-1665
Authors:
Taieb, J
Benattar, C
Birr, AS
Lindenbaum, A
Frydman, R
Olivennes, F
Citation: J. Taieb et al., Delayed assessment of serum and whole blood estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone kept at room temperature or refrigerated, FERT STERIL, 74(5), 2000, pp. 1053-1054
Authors:
Fanchin, R
Righini, C
Ayoubi, JM
Olivennes, F
de Ziegler, D
Frydman, R
Citation: R. Fanchin et al., New look at endometrial echogenicity: objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer, FERT STERIL, 74(2), 2000, pp. 274-281
Authors:
Fanchin, R
de Ziegler, D
Taieb, J
Olivennes, F
Castracane, VD
Frydman, R
Citation: R. Fanchin et al., Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation, FERT STERIL, 73(2), 2000, pp. 275-279
Authors:
Olivennes, F
Belaisch-Allart, J
Emperaire, JC
Dechaud, H
Alvarez, S
Moreau, L
Nicollet, B
Zorn, JR
Bouchard, P
Frydman, R
Citation: F. Olivennes et al., Prospective, randomized, controlled study of in vitro fertilization-embryotransfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin), FERT STERIL, 73(2), 2000, pp. 314-320
Authors:
Patrat, C
Wolf, JP
Epelboin, S
Hugues, JN
Olivennes, F
Granet, P
Zorn, JR
Jouannet, P
Citation: C. Patrat et al., Pregnancies, growth and development of children conceived by subzonal injection of spermatozoa, HUM REPR, 14(9), 1999, pp. 2404-2410
Authors:
Rongieres-Bertrand, C
Olivennes, F
Righini, C
Fanchin, R
Taieb, J
Hamamah, S
Bouchard, P
Frydman, R
Citation: C. Rongieres-bertrand et al., Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation, HUM REPR, 14(3), 1999, pp. 683-688
Authors:
Fanchin, R
Righini, C
Olivennes, F
Taieb, J
de Ziegler, D
Frydman, R
Citation: R. Fanchin et al., Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation, FERT STERIL, 71(1), 1999, pp. 174-181
Authors:
Perez, C
Koeppel, B
Olivennes, F
Bertrand-Rongieres, C
Fanchin, R
Righini, C
Frydman, R
Citation: C. Perez et al., IVF+ICSI: psychological repercussions on the couples, CONTR FER S, 26(10), 1998, pp. 713-717
Authors:
Olivennes, F
Alvarez, S
Bouchard, P
Fanchin, R
Salat-Baroux, J
Frydman, R
Citation: F. Olivennes et al., The use of a GnRH antagonist (Cetrorelix (R)) in a single dose protocol inIVF-embryo transfer: a dose finding study of 3 versus 2 mg, HUM REPR, 13(9), 1998, pp. 2411-2414
Authors:
Kadhel, P
Olivennes, F
Fernandez, H
Vial, M
Frydman, R
Citation: P. Kadhel et al., Are there still obstetric and perinatal benefits for selective embryo reduction of triplet pregnancies?, HUM REPR, 13(12), 1998, pp. 3555-3559
Risultati:
1-22
|